163 related articles for article (PubMed ID: 11090879)
1. Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase.
Blom AM; Zadura AF; Villoutreix BO; Dahlbäck B
Mol Immunol; 2000 Jun; 37(8):445-53. PubMed ID: 11090879
[TBL] [Abstract][Full Text] [Related]
2. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
Blom AM
Scand J Clin Lab Invest Suppl; 2000; 233():37-49. PubMed ID: 11317941
[TBL] [Abstract][Full Text] [Related]
3. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Blom AM; Kask L; Dahlbäck B
Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
[TBL] [Abstract][Full Text] [Related]
4. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).
Rawal N; Rajagopalan R; Salvi VP
Mol Immunol; 2009 Sep; 46(15):2902-10. PubMed ID: 19660812
[TBL] [Abstract][Full Text] [Related]
5. Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA.
Okroj M; Jenkins HT; Herbert AP; Barlow PN; Blom AM
Mol Immunol; 2008 Nov; 46(1):62-9. PubMed ID: 18715646
[TBL] [Abstract][Full Text] [Related]
6. Role of the C3b-binding site on C4b-binding protein in regulating classical pathway C5 convertase.
Rawal N; Pangburn MK
Mol Immunol; 2007 Feb; 44(6):1105-14. PubMed ID: 16979240
[TBL] [Abstract][Full Text] [Related]
7. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.
Blom AM; Villoutreix BO; Dahlbäck B
J Biol Chem; 2003 Oct; 278(44):43437-42. PubMed ID: 12893820
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional studies of complement inhibitor C4b-binding protein.
Blom AM
Biochem Soc Trans; 2002 Nov; 30(Pt 6):978-82. PubMed ID: 12440957
[TBL] [Abstract][Full Text] [Related]
9. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
Thielens NM; Colomb MG
Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
[TBL] [Abstract][Full Text] [Related]
10. Binding of complement inhibitor C4b-binding protein to a highly virulent Streptococcus pyogenes M1 strain is mediated by protein H and enhances adhesion to and invasion of endothelial cells.
Ermert D; Weckel A; Agarwal V; Frick IM; Björck L; Blom AM
J Biol Chem; 2013 Nov; 288(45):32172-32183. PubMed ID: 24064215
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the active sites in decay-accelerating factor.
Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
[TBL] [Abstract][Full Text] [Related]
12. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function.
Härdig Y; Hillarp A; Dahlbäck B
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):469-75. PubMed ID: 9163340
[TBL] [Abstract][Full Text] [Related]
13. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
14. A cluster of positively charged amino acids in the C4BP alpha-chain is crucial for C4b binding and factor I cofactor function.
Blom AM; Webb J; Villoutreix BO; Dahlbäck B
J Biol Chem; 1999 Jul; 274(27):19237-45. PubMed ID: 10383431
[TBL] [Abstract][Full Text] [Related]
15. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
Seya T; Holers VM; Atkinson JP
J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
[TBL] [Abstract][Full Text] [Related]
16. Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4.
Duncan RC; Bergström F; Coetzer TH; Blom AM; Wijeyewickrema LC; Pike RN
Mol Immunol; 2012 Jan; 49(4):593-600. PubMed ID: 22071314
[TBL] [Abstract][Full Text] [Related]
17. Formation of high affinity C5 convertase of the classical pathway of complement.
Rawal N; Pangburn MK
J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for the complement regulatory activities of C4BP.
Blom AM; Kask L; Dahlbäck B
J Biol Chem; 2001 Jul; 276(29):27136-44. PubMed ID: 11369776
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system.
Maeda S; Nagasawa S
Biochem J; 1990 Nov; 271(3):749-54. PubMed ID: 2244876
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal anti-human C4b antibodies: stabilization and inhibition of the classical-pathway C3 convertase.
Ichihara C; Nakamura T; Nagasawa S; Koyama J
Mol Immunol; 1986 Feb; 23(2):151-7. PubMed ID: 2422544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
